Nimh sbir phase 1 topic 001- point-of-care HIV viral load and drug adherence assays
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95024C00040
- Awardee
-
Vitruvian Bio, LLC UEI JHJJANE1ALC6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,999
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $299,999.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21202, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $299,999 |
About this award
This federal contract award is for a $299,999 Small Business Innovation Research (SBIR) Phase 1 contract issued by the National Institute of Mental Health (NIMH), which is part of the National Institutes of Health (NIH). The contract was awarded to Vitruvian Bio, LLC, a small, woman-owned, and disadvantaged business, to develop point-of-care assays for measuring HIV viral load and drug adherence. This contract is part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR program, which aims to stimulate innovation, strengthen the role of small businesses in federal research and development, and increase commercialization of federally-funded technologies. The contract has a firm fixed price and an ultimate completion date of September 22, 2025.
Quick answers
Who was awarded contract 75N95024C00040?
75N95024C00040 was awarded to Vitruvian Bio, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2024.
How much is contract 75N95024C00040 worth?
The government has obligated $299,999 on 75N95024C00040.
Was contract 75N95024C00040 competed?
The extent of competition for 75N95024C00040 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award